Completed NA INTERVENTIONAL 1-arm
NCT00834223
A Prospective, Multicenter, Open-label, Safety and Preliminary Efficacy Study of the Surgical Implantation of OPKO's Glaucoma Drainage Device (AquashuntTM) in Patients With Refractory Chronic Forms of Open Angle Glaucoma (OAG)
Sponsor: OPKO Health, Inc.
Conditions
Glaucoma
Interventions
Aquashunt
Updated 5 times since 2017 Last updated: Mar 31, 2011 Started: Jan 31, 2009 Primary completion: Sep 30, 2009 Completion: May 31, 2010
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Glaucoma, this trial is completed. The trial is conducted by OPKO Health, Inc. and has accumulated 5 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Jan 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- OPKO Health, Inc.
Data source: OPKO Health, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .